The ESMINT Research Committee
Dr Francis Turjman chairs the ESMINT Research Committee. The Committee is available to help members in communicating details of research to the ESMINT Community. The goals are to assist in collaborative research by European centres and to aid setting up of clinical trials. The committee assists both clinical and fundamental research and wishes to establish ESMINT Research Awards.
Currently, ESMINT supports an audit of the long term follow up of patients treated with Flow Diverters in order to establish data on the risks of delayed spontaneous haemorrhage. This study is co-ordinated by Pr. István Szikora of the Neurological Institute of Budapest.
Members are invited to contact Dr Turjman with suggestions and to register their interest in any of the ESMINT sponsored programs or trials.
The ESMINT Stroke Grant 2017
ESMINT offers again a grant for a one-year research fellowship to a young physician to support his/her training in research related to stroke endovascular management in European laboratories or clinics.
The beneficiary of this program will be supported with 13.500 US $. The application deadline is August 15, 2017.
More information about the ESMINT Stroke Grant.
Positive trials presented at International Stroke Conference
February 11, 2015 will be an important milestone in the history of Interventional Neuroradiology.
Three positive trials (ESCAPE, EXTEND-IA, and SWIFT-PRIME), evaluating mechanical thrombectomy in acute ischemic stroke, were presented to the applause of a large audience.
Results of the MrCLEAN clinical trial published by NEJM
Today, December 17th 2014, the New England Journal of Medicine published the results of the MrCLEAN trial. The results of this trial are strongly positive towards intra arterial therapy, and will have a major impact on the future treatment of ischemic stroke.
Join the Giant Intracranial Aneurysm Registry
The aim of this international registry is to collect data on how patients present, to discover what kind of therapies are conducted and to learn how the patients' health status develops over a follow-up period of 5 years. Information, study protocols and data collection sheets available here.
> Find out more